View in EDS HTML Full Text PDF Full Text

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.

Saved in:
Bibliographic Details
Title: First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.
Authors: Zhao, Ruiyue1 (AUTHOR), Ke, Miao1 (AUTHOR), Lv, Jie1 (AUTHOR), Liu, Shaoyu1 (AUTHOR), Liu, Yuheng1 (AUTHOR), Zhang, Jing1 (AUTHOR), Xu, Lifu1 (AUTHOR), Gu, Di2 (AUTHOR), Li, Mingzhao2 (AUTHOR), Cai, Chao2 (AUTHOR), Liu, Yongda2 (AUTHOR), Zeng, Guohua2 (AUTHOR), Alexoff, David3 (AUTHOR), Ploessl, Karl3 (AUTHOR), Zhu, Lin1,4 (AUTHOR) zhulin111@gmail.com, Kung, Hank F.3,5 (AUTHOR) kunghf@gmail.com, Wang, Xinlu1 (AUTHOR) 71lu@163.com
Source: European Journal of Nuclear Medicine & Molecular Imaging. May2024, Vol. 51 Issue 6, p1753-1762. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-024-06596-y